ENDO 2016 Bone Health News Conference

Researchers shared insights on the effects of attention-deficit hyperactivity disorder medications and anti-depressants on bone health during the April 3, 2016, news conference. In addition, researchers presented the results of a phase 3 trial for the osteoporosis drug abaloparatide-SC.